{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:12:18Z","timestamp":1770354738497,"version":"3.49.0"},"posted":{"date-parts":[[2024,4,2]]},"group-title":"Neuroscience","reference-count":76,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Converging findings have established that the endocannabinoid (eCB) system serves as a possible target for the development of new treatments for pain as a complement to opioid-based treatments. Here we show in male and female mice that enhancing levels of the eCB, 2-arachidonoylglycerol (2-AG), through pharmacological inhibition of its catabolic enzyme, monoacylglycerol lipase (MAGL), either systemically or in the ventral tegmental area (VTA) with JZL184, leads to a substantial attenuation of the rewarding effects of opioids in male and female mice using conditioned place preference and self-administration paradigms, without altering their analgesic properties. These effects are driven by CB1 receptors (CB1Rs) within the VTA as VTA CB1R conditional knockout, counteracts JZL184\u2019s effects. Conversely, pharmacologically enhancing the levels of the other eCB, anandamide (AEA), by inhibition of fatty acid amide hydrolase (FAAH) has no effect on opioid reward or analgesia. Using fiber photometry with fluorescent sensors for calcium and dopamine (DA), we find that enhancing 2-AG levels diminishes opioid reward-related nucleus accumbens (NAc) activity and DA neurotransmission. Together these findings reveal that 2-AG counteracts the rewarding properties of opioids and provides a potential adjunctive therapeutic strategy for opioid-related analgesic treatments.<\/jats:p>","DOI":"10.1101\/2024.04.02.585967","type":"posted-content","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T21:45:13Z","timestamp":1712094313000},"source":"Crossref","is-referenced-by-count":2,"title":["Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia"],"prefix":"10.64898","author":[{"given":"Arlene","family":"Mart\u00ednez-Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Fetcho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizzie","family":"Birmingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin X","family":"Jiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Careen","family":"Foord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Scala-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narmin","family":"Mekawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Pleil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia M.","family":"Pickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Liston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos M.","family":"Castorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Levitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Xian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Briand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali M.","family":"Rajadhyaksha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024040505200595000_2024.04.02.585967v1.1","unstructured":"NIDA. National Institute of Drug Abuse; 2018."},{"key":"2024040505200595000_2024.04.02.585967v1.2","doi-asserted-by":"crossref","unstructured":"Volkow ND , and Blanco C . The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2020.","DOI":"10.1038\/s41380-020-0661-4"},{"key":"2024040505200595000_2024.04.02.585967v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.166"},{"key":"2024040505200595000_2024.04.02.585967v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.143"},{"key":"2024040505200595000_2024.04.02.585967v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0137-5"},{"key":"2024040505200595000_2024.04.02.585967v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2015.01.002"},{"key":"2024040505200595000_2024.04.02.585967v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.11.010"},{"issue":"5","key":"2024040505200595000_2024.04.02.585967v1.8","doi-asserted-by":"crossref","first-page":"e13220","DOI":"10.1111\/adb.13220","article-title":"Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in rats","volume":"27","year":"2022","journal-title":"Addict Biol"},{"key":"2024040505200595000_2024.04.02.585967v1.9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1451-21.2021"},{"key":"2024040505200595000_2024.04.02.585967v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.268"},{"issue":"7","key":"2024040505200595000_2024.04.02.585967v1.11","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11064-012-0739-8","article-title":"Dynamic changes of tyrosine hydroxylase and dopamine concentrations in the ventral tegmental area-nucleus accumbens projection during the expression of morphine-induced conditioned place preference in rats","volume":"37","year":"2012","journal-title":"Neurochem Res"},{"key":"2024040505200595000_2024.04.02.585967v1.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0803-7"},{"issue":"2","key":"2024040505200595000_2024.04.02.585967v1.13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/syn.10025","article-title":"In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol","volume":"43","year":"2002","journal-title":"Synapse"},{"key":"2024040505200595000_2024.04.02.585967v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.07.028"},{"key":"2024040505200595000_2024.04.02.585967v1.15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2016.11.015","article-title":"The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice","volume":"114","year":"2017","journal-title":"Neuropharmacology"},{"key":"2024040505200595000_2024.04.02.585967v1.16","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.222315"},{"key":"2024040505200595000_2024.04.02.585967v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300848"},{"key":"2024040505200595000_2024.04.02.585967v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.11.018"},{"key":"2024040505200595000_2024.04.02.585967v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14782"},{"key":"2024040505200595000_2024.04.02.585967v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/384083a0"},{"key":"2024040505200595000_2024.04.02.585967v1.21","doi-asserted-by":"crossref","unstructured":"Jasinski D . Assessment of the abuse potentiality of morphinelike drugs (methods used in man). . Springer, Berlin; 1977.","DOI":"10.1007\/978-3-642-66612-4_4"},{"key":"2024040505200595000_2024.04.02.585967v1.22","unstructured":"Koob GR . Animal models of drug addiction. . Raven Press Ltd., New York; 1995."},{"key":"2024040505200595000_2024.04.02.585967v1.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2007.00070.x"},{"key":"2024040505200595000_2024.04.02.585967v1.24","doi-asserted-by":"publisher","DOI":"10.1021\/bi701378g"},{"key":"2024040505200595000_2024.04.02.585967v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.129"},{"issue":"1","key":"2024040505200595000_2024.04.02.585967v1.26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors","volume":"8","year":"2018","journal-title":"Transl Psychiatry"},{"key":"2024040505200595000_2024.04.02.585967v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.02.013"},{"key":"2024040505200595000_2024.04.02.585967v1.28","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2437"},{"key":"2024040505200595000_2024.04.02.585967v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/42015"},{"key":"2024040505200595000_2024.04.02.585967v1.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115231108"},{"key":"2024040505200595000_2024.04.02.585967v1.31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88760"},{"key":"2024040505200595000_2024.04.02.585967v1.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5274"},{"key":"2024040505200595000_2024.04.02.585967v1.33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.26.12304"},{"key":"2024040505200595000_2024.04.02.585967v1.34","doi-asserted-by":"crossref","unstructured":"Corre J , et al. Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement. Elife. 2018;7.","DOI":"10.7554\/eLife.39945"},{"key":"2024040505200595000_2024.04.02.585967v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.10.021"},{"key":"2024040505200595000_2024.04.02.585967v1.36","doi-asserted-by":"crossref","unstructured":"Bavley CC , et al. Cocaine- and stress-primed reinstatement of drug-associated memories elicit differential behavioral and frontostriatal circuit activity patterns via recruitment of L-type Ca(2+) channels. Mol Psychiatry. 2019;[Epub ahead of print].","DOI":"10.1038\/s41380-019-0624-9"},{"issue":"6","key":"2024040505200595000_2024.04.02.585967v1.37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.neuron.2018.08.041","article-title":"The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior","volume":"99","year":"2018","journal-title":"Neuron"},{"key":"2024040505200595000_2024.04.02.585967v1.38","doi-asserted-by":"crossref","unstructured":"Li A , et al. Role of BDNF in the development of an OFC-amygdala circuit regulating sociability in mouse and human. Mol Psychiatry. 2019.","DOI":"10.1038\/s41380-019-0422-4"},{"key":"2024040505200595000_2024.04.02.585967v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.05.009"},{"key":"2024040505200595000_2024.04.02.585967v1.40","doi-asserted-by":"crossref","first-page":"632757","DOI":"10.3389\/fphar.2021.632757","article-title":"The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area","volume":"12","year":"2021","journal-title":"Front Pharmacol"},{"key":"2024040505200595000_2024.04.02.585967v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/nrn4004"},{"key":"2024040505200595000_2024.04.02.585967v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.126"},{"key":"2024040505200595000_2024.04.02.585967v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.12.012"},{"key":"2024040505200595000_2024.04.02.585967v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.04.026"},{"key":"2024040505200595000_2024.04.02.585967v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301127"},{"key":"2024040505200595000_2024.04.02.585967v1.46","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4152-06.2007"},{"key":"2024040505200595000_2024.04.02.585967v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300848"},{"key":"2024040505200595000_2024.04.02.585967v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.06.046"},{"key":"2024040505200595000_2024.04.02.585967v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2014.02.002"},{"key":"2024040505200595000_2024.04.02.585967v1.50","doi-asserted-by":"crossref","unstructured":"Covey DP , et al. Chronic augmentation of endocannabinoid levels persistently increases dopaminergic encoding of reward cost and motivation. J Neurosci. 2021.","DOI":"10.1523\/JNEUROSCI.0285-21.2021"},{"key":"2024040505200595000_2024.04.02.585967v1.51","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.218677"},{"key":"2024040505200595000_2024.04.02.585967v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.06.020"},{"key":"2024040505200595000_2024.04.02.585967v1.53","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.166"},{"key":"2024040505200595000_2024.04.02.585967v1.54","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201426"},{"key":"2024040505200595000_2024.04.02.585967v1.55","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2616"},{"key":"2024040505200595000_2024.04.02.585967v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300754"},{"key":"2024040505200595000_2024.04.02.585967v1.57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence","volume":"10","year":"2019","journal-title":"Front Pharmacol"},{"key":"2024040505200595000_2024.04.02.585967v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705792"},{"key":"2024040505200595000_2024.04.02.585967v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.04.030"},{"key":"2024040505200595000_2024.04.02.585967v1.60","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4570-11.2011"},{"key":"2024040505200595000_2024.04.02.585967v1.61","doi-asserted-by":"publisher","DOI":"10.1002\/cne.21983"},{"key":"2024040505200595000_2024.04.02.585967v1.62","doi-asserted-by":"publisher","DOI":"10.1002\/cne.21891"},{"key":"2024040505200595000_2024.04.02.585967v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-0657-z"},{"issue":"4","key":"2024040505200595000_2024.04.02.585967v1.64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuron.2020.02.029","article-title":"Periaqueductal Gray and Rostromedial Tegmental Inhibitory Afferents to VTA Have Distinct Synaptic Plasticity and Opiate Sensitivity","volume":"106","year":"2020","journal-title":"Neuron"},{"key":"2024040505200595000_2024.04.02.585967v1.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.03.066"},{"key":"2024040505200595000_2024.04.02.585967v1.66","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-018-1761-7.Gene"},{"key":"2024040505200595000_2024.04.02.585967v1.67","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.302"},{"key":"2024040505200595000_2024.04.02.585967v1.68","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1493-22.2022"},{"key":"2024040505200595000_2024.04.02.585967v1.69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12399-z"},{"key":"2024040505200595000_2024.04.02.585967v1.70","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13005"},{"key":"2024040505200595000_2024.04.02.585967v1.71","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.71"},{"key":"2024040505200595000_2024.04.02.585967v1.72","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.271"},{"issue":"12","key":"2024040505200595000_2024.04.02.585967v1.73","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/mp.2017.9","article-title":"Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens","volume":"22","year":"2017","journal-title":"Mol Psychiatry"},{"key":"2024040505200595000_2024.04.02.585967v1.74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131752"},{"issue":"10","key":"2024040505200595000_2024.04.02.585967v1.75","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41380-019-0513-2","article-title":"Cocaine- and stress-primed reinstatement of drug-associated memories elicit differential behavioral and frontostriatal circuit activity patterns via recruitment of L-type Ca(2+) channels","volume":"25","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2024040505200595000_2024.04.02.585967v1.76","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00044.2021"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.04.02.585967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:13:41Z","timestamp":1768457621000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.04.02.585967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1101\/2024.04.02.585967","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1126\/sciadv.adq4779","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,4,2]]},"subtype":"preprint"}}